Stories about Ministry of Health, Labour and Welfare
-
Language:
English
-
Media:
All
- Period:
- Period:Total
- more
Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
moreOrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent
moreNew Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
moreMerck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations
moreUpdated Results for Investigational Therapy Tepotinib Presented at WCLC 2019
moreSysmex obtains Japanese manufacturing and marketing approval for the first blood-based RAS mutation testing for colorectal cancer
moreOzempic® Superior in Lowering Blood Sugar and Weight Vs Placebo, Both in Combination with SGLT-2 Inhibitors
moreOzempic® Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk Regardless of Prior CV Events at Baseline
more
1